LEADER 01068nam0-22003011i-450- 001 990006596850403321 005 20001010 035 $a000659685 035 $aFED01000659685 035 $a(Aleph)000659685FED01 035 $a000659685 100 $a20001010d--------km-y0itay50------ba 101 0 $aita 105 $ay-------001yy 200 1 $aCompetence judiciarie et effets des juge ments dans le marche' commun (Etude de la Convention de Bruxellesa du 27 septembre 1968)$fGeorges A.L. Droz$gpreface de Henri Batiffol. 210 $aParis$cDalloz$d1972 215 $aXII, 577 p., 22 cm 225 1 $aBibliothèque de droit international privé$v13 700 1$aDroz,$bGeorges A. L.$0239414 702 1$aBatiffol,$bHenri 801 0$aIT$bUNINA$gRICA$2UNIMARC 901 $aBK 912 $a990006596850403321 952 $aCOLLEZ. 453 (13)$b6602$fFSPBC 959 $aFSPBC 996 $aCompetence judiciarie et effets des juge ments dans le marche' commun (Etude de la Convention de Bruxellesa du 27 septembre 1968$9622213 997 $aUNINA DB $aGEN01 LEADER 01365nam0-22004451i-450- 001 990005487800203316 005 20010829120000.0 035 $a000548780 035 $aUSA01000548780 035 $a(ALEPH)000548780USA01 035 $a000548780 100 $a20010829d1998-------|0enac50------ba 101 $aeng 102 $aUS 105 $a|||| ||||| 200 1 $aMatrix algebra and its applications to statistics and econometrics$fC. Radhakrishna Rao, M. Bhaskara Rao 210 $aSingapore$aNew Jersey , London$aHong Kong$cWorld Scientific$d1998 215 $a535 p.$d22 cm. 606 $aEconometria$2FI 606 $aStatistica$2FI 606 $aMatrici$2FI 620 $dLondon 620 $dSingapore 620 $dnew jersey 620 $dHong Kong 676 $a512.434 21.ed$v21 700 1$aRAO,$bCalyampudi Radhakrishna$0102152 701 1$aRAO,$bBhaskara M.$0613951 712 $aWorld Scientific 801 $aIT$bSOL$c20120104 912 $a990005487800203316 950 $aDIP.TO SCIENZE ECONOMICHE - (SA)$dDS 500 512.434 RAO$e8698 DISES 951 $a500 512.434 RAO$b8698 DISES 959 $aBK 969 $aDISES 979 $c20121027$lUSA01$h1532 979 $c20121027$lUSA01$h1613 996 $aMatrix algebra and its applications to statistics and econometrics$91128945 997 $aUNISA NUM $aUSA9352 LEADER 06192nam 22008055 450 001 9910298354003321 005 20200701160112.0 010 $a1-4614-8993-8 024 7 $a10.1007/978-1-4614-8993-1 035 $a(CKB)2550000001151684 035 $a(EBL)1538662 035 $a(SSID)ssj0001049030 035 $a(PQKBManifestationID)11623067 035 $a(PQKBTitleCode)TC0001049030 035 $a(PQKBWorkID)11033665 035 $a(PQKB)10523004 035 $a(MiAaPQ)EBC1538662 035 $a(DE-He213)978-1-4614-8993-1 035 $a(PPN)176100253 035 $a(EXLCZ)992550000001151684 100 $a20131024d2014 u| 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aNanotoxicology $eMaterials, Methodologies, and Assessments /$fedited by Nelson Durán, Silvia S. Guterres, Oswaldo L. Alves 205 $a1st ed. 2014. 210 1$aNew York, NY :$cSpringer New York :$cImprint: Springer,$d2014. 215 $a1 online resource (415 p.) 225 1 $aNanomedicine and Nanotoxicology,$x2194-0452 300 $aDescription based upon print version of record. 311 $a1-4614-8992-X 320 $aIncludes bibliographical references and index. 327 $aForeword -- Preface -- Chapter 1: Nanomaterials -- Chapter 2: Concepts and Methodology of Interaction of Carbon Nanostructures with Cellular Systems -- Chapter 3: Nanostability -- Chapter 4: Pharmacokinetics and Phamacodynamics of Nanomaterials -- Chapter 5: In Vitro Cytotoxicity Assays of Nanoparticles on Different Cell Lines -- Chapter 6: Carbon Nanotubes: From Synthesis to Genotoxicity -- Chapter 7: From Combinatorial Display Techniques to Microarray Technology: New Approaches to the Development and Toxicological Profiling of Targeted Nanomedicines -- Chapter 8: Genetic Studies on the Effects of Nanomaterials -- Chapter 9: Cellular Mechanisms in Nanomaterial Internalization, Intracellular Trafficking and Toxicity -- Chapter 10: Cytotoxicity and Genotoxicity of Solid Lipid Nanoparticles -- Chapter 11: Cytotoxicity and Genotoxicity of Biogenically Synthesized Silver Nanoparticles -- Chapter 12: Cytotoxicity and Genotoxicity of Iron Oxides Nanoparticles -- Chapter 13: Poloxamers as Drug-Delivery Systems: Physico-Chemical, Pharmaceutical And Toxicological Aspects -- Chapter 14: Polymeric Nanoparticles: In Vivo Toxicological Evaluation, Cardiotoxicity and Hepatotoxicity -- Chapter 15: Cyto,Geno and Ecotoxicity of Copper Nanoparticles -- Chapter 16: Accessing the Erythrocyte Toxicity of Nanomaterials: From Current Methods to Biomolecular Surface Chemistry Interactions -- Index. 330 $aThis book takes a systematic approach to nanotoxicology and the developing risk factors associated with  nanosized particles during manufacture and use of nanotechnology. Beginning with a detailed introduction to engineered nanostructures, the first part of the book presents concepts and definitions of nanomaterials from quantum dots to graphene to fullerenes, with detailed discussion of functionalization, stability, and medical and biological applications. The second part critically examines methodologies used to assess cytotoxicity and genotoxicity. Coverage includes interactions with blood (erythrocytes), combinatorial and microarray techniques, cellular mechanisms, and ecotoxicology assessments. Part three describes cases studies both in vitro and in vivo for specific nanomaterials including solid lipid nanoparticles and nanostructured lipid carriers and metallic nanoparticles and metallic oxides. New information is also presented on toxicological aspects of poloxamers and polymeric nanoparticles as drug carriers as well as size effects on cytotoxicity and genotoxicity. Didactic aspects are emphasized in all chapters, making the book suitable for a broad audience ranging from advanced undergraduate and graduate students to researchers in academia and industry. In all, Nanotoxicology: Materials, Methodologies, and Assessments will provide comprehensive insight into biological and environmental interactions with nanostructures. Provides an introduction to nanostructures actually in use Describes cyto- and genotoxicity methodologies, and assesses their performance in comparison to common toxicity assays Discusses the relation of cytotoxicity and genotoxicity to ecotoxicity Presents a range of applications, from biogenic silver nanoparticles to poloxamers as drug-delivery systems, reflecting the expanding applications of nanotechnology. 410 0$aNanomedicine and Nanotoxicology,$x2194-0452 606 $aPharmacology 606 $aNanochemistry 606 $aEnvironmental toxicology 606 $aNanotechnology 606 $aNanoscience 606 $aNanoscience 606 $aNanostructures 606 $aPharmacology/Toxicology$3https://scigraph.springernature.com/ontologies/product-market-codes/B21007 606 $aNanochemistry$3https://scigraph.springernature.com/ontologies/product-market-codes/C33000 606 $aEcotoxicology$3https://scigraph.springernature.com/ontologies/product-market-codes/U25001 606 $aNanotechnology$3https://scigraph.springernature.com/ontologies/product-market-codes/Z14000 606 $aNanoscale Science and Technology$3https://scigraph.springernature.com/ontologies/product-market-codes/P25140 615 0$aPharmacology. 615 0$aNanochemistry. 615 0$aEnvironmental toxicology. 615 0$aNanotechnology. 615 0$aNanoscience. 615 0$aNanoscience. 615 0$aNanostructures. 615 14$aPharmacology/Toxicology. 615 24$aNanochemistry. 615 24$aEcotoxicology. 615 24$aNanotechnology. 615 24$aNanoscale Science and Technology. 676 $a541.2 676 $a615.1/901 702 $aDurán$b Nelson$4edt$4http://id.loc.gov/vocabulary/relators/edt 702 $aGuterres$b Silvia S$4edt$4http://id.loc.gov/vocabulary/relators/edt 702 $aAlves$b Oswaldo L$4edt$4http://id.loc.gov/vocabulary/relators/edt 906 $aBOOK 912 $a9910298354003321 996 $aNanotoxicology$92052322 997 $aUNINA